Back to Journals » ImmunoTargets and Therapy » Volume 6

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer

Total article views   HTML views PDF downloads Totals
10,286 Dovepress* 9,075+ 1,935 11,010
PubMed Central* 1,211 366 1,577
Totals 10,286 2,301 12,587
*Since 20 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar